TITLE

Molecular mechanisms of lung disease

PUB. DATE
December 2005
SOURCE
Thorax;Dec2005 Supplement 2, Vol. 60, pii78
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts of the molecular mechanism of lung disease. They include "Longitudinal Proteomic Analysis of Spontaneous Sputum to Assess Lung Inflammation in Cystic Fibrosis," by R.D. Gray, M. Imrie, A.C. Boyd, J.A. Innes, and A.P. Greening, "Methylation and Conservation Analysis of CPG Islands in the Adam33 Gene," by Y. Yang, H.M. Haitchi, S. Puddicombe, R. Hayes, S.T. Holgate, and D.E. Davies, and "Codon 178 Genetic Polymorphism of the DNA Repair Protein O6-Methylguanine-DNA Methyltransferase and Lung Cancer," by P.A.J. Crosbie, A.C. Povey, G. McGown, M.R. Thorncroft, R. Agius, P.V. Barber, M.F. Santibanez-Koref, and G.P. Margison.
ACCESSION #
19836647

 

Related Articles

  • The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis. .Marson, Fernando A. L.; Bertuzzo, Carmen S.; Hortencio, Ta¡s D. R.; Ribeiro, Jos‚ D.; Bonadia, Luciana C.; Ribeiro, Ant“nio F. // BMC Pulmonary Medicine;2012, Vol. 12 Issue 1, p41 

    Background: Cystic Fibrosis (CF) is a monogenic disease with complex expression because of the action of genetic and environmental factors. We investigated whether the ACE gene D/I polymorphism is associated with severity of CF. Methods: A cross-sectional study was performed, from 2009 to 2011,...

  • Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity. Taylor-Cousar, Jennifer L.; Zariwala, Maimoona A.; Burch, Lauranell H.; Pace, Rhonda G.; Drumm, Mitchell L.; Calloway, Hollin; Haiying Fan; Weston, Brent W.; Wright, Fred A.; Knowles, Michael R. // PLoS ONE;2009, Vol. 4 Issue 1, p1 

    Background: The pulmonary phenotype in cystic fibrosis (CF) is variable; thus, environmental and genetic factors likely contribute to clinical heterogeneity. We hypothesized that genetically determined ABO histo-blood group antigen (ABH) differences in glycosylation may lead to differences in...

  • Gene therapy: the case for cystic fibrosis. Alton, Eric WFW; Geddes, Duncan // Journal of the Royal Society of Medicine (Supplement);Feb1997, Vol. 90 Issue 31, p43 

    The article discusses a study which investigated the use of gene therapy in the treatment of cystic fibrosis. The study suggested that liposome-mediated cystic fibrosis transmembrane conductance regulator gene transfer may be a practical option for initial studies of gene transfer into cystic...

  • Lung inflammation: Disarming neutrophils in cystic fibrosis. Leavy, Olive // Nature Reviews Immunology;Jan2008, Vol. 8 Issue 1, p8 

    The article presents a medical research in Great Britain on reducing neutrophils in cystic fibrosis. It is said that the accumulation of neutrophils and high concentrations of the chemokine interleukin-8 (IL-8) in the airways is a characteristic feature of chronic lung diseases. However, further...

  • Myeloperoxidase Promoter Polymorphism -463G Is Associated With More Severe Clinical Expression of Cystic Fibrosis Pulmonary Disease. Reynolds, Wanda F.; Sermet-Gaudelus, Isabelle; Gausson, Val�rie; Feuillet, Marie-No�lle; Bonnefont, Jean-Paul; Lenoir, G�rard; Descamps-Latscha, B�atrice; Witko-Sarsat, V�ronique // Mediators of Inflammation;4/1/2006, Vol. 2006 Issue 2, p1 

    The severity of cystic fibrosis (CF) pulmonary disease is not directly related to CFTR genotype but depends upon several parameters, including neutrophil-dominated inflammation. Identification of agents modulating inflammation constitutes a relevant goal. Myeloperoxidase (MPO) is involved in...

  • ADRA2A IS A CYSTIC FIBROSIS MODIFIER GENE. MARSON, F. A. L.; REZENDE, L. M.; FURGERI, D. T.; RIBEIRO, A. F.; RIBEIRO, J. D.; BERTUZZO, C. S. // International Journal of Genetics;2013, Vol. 5 Issue 1, p125 

    Background: Cystic fibrosis (CF) is an autosomal disease with characteristics of a complex disease. Understanding ADRA2A polymorphisms are important to elucidate clinical variability that is encountered in inflammatory diseases including CF, for which diabetes is an important comorbidity beyond...

  • Promoter variants in tissue inhibitor of metalloproteinase-3 (TIMP-3) protect against susceptibility in pigeon breeders' disease. Hill, M. R.; Briggs, I.; Montaña, M. M.; Estrada, A.; Laurent, G. J.; Selman, M.; Pordo, A. // Thorax;Jul2004, Vol. 59 Issue 7, p586 

    Background: Tissue inhibitors of metalloproteinases (TIMPs) play a major role in extracellular matrix turnover in the lung. However, in chronic lung disorders such as idiopathic pulmonary fibrosis (IPF) and pigeon breeders' disease (PBD), TIMPs may promote an adverse non-degradative environment....

  • AGER -429T/C Is Associated with an Increased Lung Disease Severity in Cystic Fibrosis. Beucher, Julie; Boëlle, Pierre-Yves; Busson, Pierre-François; Muselet-Charlier, Cé line; Clement, Annick; Corvol, Harriet // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    The clinical course of cystic fibrosis (CF) varies between patients bearing identical CFTR mutations, suggesting the involvement of modifier genes. We assessed the association of lung disease severity with the variant AGER -429 T/C, coding for RAGE, a pro-inflammatory protein, in CF patients...

  • Mutation Analysis of Exons 10 and 17a of CFTR Gene in Patients with Cystic Fibrosis in Kermanshah Province, Western Iran. Sahami, Abbas; Alibakhshi, Reza; Ghadiri, Keyghobad; Sadeghi, Hamid // Journal of Reproduction & Infertility;Jan-Mar2014, Vol. 15 Issue 1, p49 

    Background: Cystic fibrosis (CF) is the most common genetic disorder with autosomal recessive inheritance among Caucasian populations. So far, more than 1950 different mutations were identified in cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR gene has 27 exons. The type...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics